Re:High US health care spending explained by its high materi...
by malandrew on Monday March 13, 2017 @01:31AM
(#13855456)
What percent of new medicines and treatments developed are developed in Canada? How does that compare to the US?
[ Parent
| on HN ]
Re:High US health care spending explained by its high materi...
by arcticbull on Monday March 13, 2017 @04:07AM
(#13856023)
Based on conversations in other threads, it has been posited that it isn't the profit motive pushing that but rather the US governments' heavy investment in drug research [1], [2].
Canada doesn't have a big drug sector to the best of my knowledge though playing along, plenty of countries with socialized medicine do:
Denmark has Novo Nordisk.
Germany has Boeringer Ingelheim and Bayer.
Switzerland has Roche.
Astra/Zeneca is Swedish/British.
GlaxoSmithKlein is British.
Sanofi is French.
Novartis is Swiss.
Actually, of the top 10 by revenue, only two (Johnson and Johnson, and Pfizer, #1 and #3 respectively) are American. All the rest are European. Assuming based on the references that development has more to do with funding, I'm willing to bet the EU spends an awful lot.